AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 195 filers reported holding AXSOME THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 1.10 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,300,810 | +16.6% | 18,102 | +25.2% | 0.24% | +4.3% |
| Q4 2022 | $1,115,146 | -52.0% | 14,458 | -72.2% | 0.23% | -54.3% |
| Q3 2022 | $2,324,000 | +18.6% | 52,092 | +1.8% | 0.50% | +5.6% |
| Q2 2022 | $1,959,000 | -18.7% | 51,160 | +74.6% | 0.48% | -10.3% |
| Q2 2020 | $2,410,000 | -45.5% | 29,293 | -61.1% | 0.53% | -61.2% |
| Q1 2020 | $4,426,000 | -40.2% | 75,235 | +5.1% | 1.37% | -15.6% |
| Q4 2019 | $7,396,000 | +182.0% | 71,556 | -44.8% | 1.63% | +134.4% |
| Q3 2019 | $2,623,000 | -31.4% | 129,584 | -12.7% | 0.69% | -25.8% |
| Q2 2019 | $3,823,000 | +18.2% | 148,471 | -34.7% | 0.94% | +17.9% |
| Q1 2019 | $3,234,000 | – | 227,241 | – | 0.79% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,132,645 | $37,332,000 | 32.86% |
| MORGAN JESS S & CO INC | 113,430 | $3,739,000 | 2.47% |
| Fairmount Funds Management LLC | 187,598 | $6,183,000 | 2.25% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 1,423,653 | $46,924,000 | 1.43% |
| WMS Partners, LLC | 250,000 | $8,240,000 | 1.21% |
| Beck Bode, LLC | 102,127 | $3,366,000 | 0.94% |
| RTW INVESTMENTS, LP | 1,616,497 | $53,280,000 | 0.80% |
| MPM BioImpact LLC | 110,155 | $3,631,000 | 0.56% |
| Endurant Capital Management LP | 52,048 | $1,716,000 | 0.39% |
| Bellevue Group AG | 752,945 | $24,817,000 | 0.25% |